Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV randomized trial comparing ovulation triggering strategies in IVF cycles with fresh embryo transfer
2026-526292-37-01Phase 4Authorised
- Sponsor
- Instituto de Investigación Sanitaria Hospital Clínico San Carlos
- Start
- Jul 2026
- Modality
- Small Molecules, Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in female infertility and poor ovarian response (POR) comparing Standard hCG trigger (Ovitrelle) arm, GnRH agonist trigger (Decapeptyl diario) arm and Dual trigger (Ovitrelle + Decapeptyl diario) arm (3 arms). Primary endpoint: Number of mature metaphase II oocytes. Planned start Jul 2026; status: authorised.
02
Drugs
recombinant human chorionic gonadotrophintriptorelin
03
Conditions
female infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on 2026-526292-37-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-526292-37-01.